View of ASSESSMENT OF HEPATIC STEATOSIS BY ULTRASOUND-GUIDED ATTENUATION PARAMETER AND ATORVASTATIN TREATMENT OUTCOMES IN PATIENTS WITH TYPE 2 DIABETES MELLITUS

Return to Article Details ASSESSMENT OF HEPATIC STEATOSIS BY ULTRASOUND-GUIDED ATTENUATION PARAMETER AND ATORVASTATIN TREATMENT OUTCOMES IN PATIENTS WITH TYPE 2 DIABETES MELLITUS Download Download PDF